Literature DB >> 209023

Isolation of subfractions of human very low density lipoproteins by zonal ultracentrifugation.

W Patsch, J R Patsch, G M Kostner, S Sailer, H Braunsteiner.   

Abstract

Very low density lipoproteins (VLDL) have been isolated and subfractionated on the basis of their differing flotation rates. The procedure consists of a single 45-min zonal ultracentrifugation step using a linear density gradient of d = 1.00 to 1.15 g/ml. Appropriate fractions of the zonal rotor effluent containing the entire VLDL spectrum were characterized by analytical ultracentrifugation, gel filtration chromatography, and complete chemical analysis. Flotation rates of VLDL subspecies from hypertriglyceridemic and normolipemic plasmas correlated directly with their Stokes radii and triglyceride content and inversely with their proportion of cholesterol, cholesteryl esters, phospholipids, and total protein. There was also an inverse correlation of flotation rate with the fraction of tetramethylurea-insoluble protein. This procedure provides a reliable methodology for a rapid isolation of VLDL subfractions and the accurate determination of their flotation rates.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 209023

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro.

Authors:  J R Patsch; A M Gotto; T Olivercrona; S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

2.  Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels.

Authors:  M T Pedrini; M Kranebitter; A Niederwanger; S Kaser; J Engl; P Debbage; L A Huber; J R Patsch
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

3.  Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

Authors:  S Eisenberg; D Gavish; Y Oschry; M Fainaru; R J Deckelbaum
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

4.  Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.

Authors:  E S Krul; M J Tikkanen; T G Cole; J M Davie; G Schonfeld
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

5.  Effect of fatty acids on lipid and apoprotein secretion and association in hepatocyte cultures.

Authors:  W Patsch; T Tamai; G Schonfeld
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

6.  Structure, immunology, and cell reactivity of low density lipoprotein from umbilical vein of a newborn type II homozygote.

Authors:  W Patsch; J L Witztum; R Ostlund; G Schonfeld
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

7.  Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.

Authors:  G Baggio; E Manzato; C Gabelli; R Fellin; S Martini; G B Enzi; F Verlato; M R Baiocchi; D L Sprecher; M L Kashyap
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

8.  Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells.

Authors:  B J McKeone; J R Patsch; H J Pownall
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Plasma lipids and lipoproteins of a patient with cholesteryl ester storage disease.

Authors:  G M Kostner; B Hadorn; A Roscher; R Zechner
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

10.  5 alpha-Cholest-8(14)-en-3 beta-ol-15-one lowers serum cholesterol and induces profound changes in the levels of lipoprotein cholesterol and apoproteins in monkeys fed a diet of moderate cholesterol content.

Authors:  G J Schroepfer; B C Sherrill; K S Wang; W K Wilson; A Kisic; T B Clarkson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.